As per the attachment

Date: 29th September, 2026 To, To, National Stock Exchange of India Limited (“NSE”), The BSE Limited (“BSE”), Listing Department Corporate Relationship Department, Exchange Plaza, 5th Floor, 2nd Floor, New Trading Ring, Plot No. C/1, G Block, Bandra-Kurla Complex Bandra P.J. Towers, Dalal Street, (East), Mumbai – 400 051. Mumbai – 400 001. NSE Symbol: STALLION BSE Scrip Code: 544342 ISIN: INE0RYC01010 ISIN: INE0RYC01010 Dear Sir/ Madam, Sub: Revised Intimation of Schedule of Analyst/Investor Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to the Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, (“SEBI Listing Regulations”), read with Part A of Schedule III to the SEBI Listing Regulations, we wish to inform you that, in continuation of our earlier intimation dated 28th September, 2026, the format of the Analyst/Investor Meeting scheduled for Thursday, 01st October, 2026 has been revised. The management of the Company will now hold individual in-person meetings with Analyst/Investors, instead of a Group Virtual Meet. The revised schedule is given below: Sr. No. Name Time (IST) Mode 1 Aditya Birla Sun Life Mutual Fund 03:30 PM In-person 2 OHM Capital 04:40 PM In-person 3 Ambit Asset Management 05:30 PM In-person Note: The above schedule is subject to change due to exigencies on the part of the Company or the concerned analysts/investors. Any changes in the schedule will be intimated to the Stock Exchanges, wherever required. No unpublished price sensitive information (UPSI) will be discussed. We request you to kindly take the same on records. Yours Faithfully, For Stallion India Fluorochemicals Limited Govind Rao Company Secretary & Compliance Officer Membership No.: A47094